Oncologist Says Experimental Drug Offers Hope—but Raises Questions—for Pancreatic Cancer Patients

Christopher Lieu, MD, of the University of Colorado Anschutz Cancer Center says daraxonrasib shows real promise for pancreatic cancer patients, while cautioning that outcomes and side effects remain uncertain.